Treatment Registry
TR-0513 ActiveRecorded September 2026

Compounded tirzepatide

Sold by Medi-Weightloss · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

TermPer monthCharged today
First month, self-pay if not insurance-coveredIntroductory

“Compounded tirzepatide $199 first month”

Per month$199Charged today$199
Price sources
Visit Medi-Weightloss

We earn nothing from this link. It opens Medi-Weightloss's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyBPI Labs, Largo FL; Innovation Compounding, Kennesaw GA; EverWell Pharmacy, Pensacola FL; Nova Specialty Pharmacy, Mansfield and Katy TX; Absolute Pharmacy, Lutz FL; Belmar Pharma Solutions; AnazaoHealth; Empower Pharmacy, Houston TX
PrescriberLive visit
CancellationMedi-Weightloss is not a contract-based program, and patients are not required to pay in advance, though some locations offer money-saving value and loyalty plans that do require advance payment.
Consult fee$199. If you self-pay, our Membership program starts with a $199 New Patient Visit — which includes a medical assessment, lab work, and GLP-1 eligibility review. Patients using insurance are told most pay between $0 and $50 per visit. Medication is priced separately from the program fee.

Not yet checked: states and membership.

Recorded from mediweightloss.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0513
Medication category
compounded tirzepatide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Medi-Weightloss — compounded tirzepatide (TR-0513). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0513

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.